ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,177Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 457

$648K Total Retail Price of All Prescriptions

Rank: 84 out of 457

581 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 581 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 581 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 9,046 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 662 450 1 2
AMLODIPINE BESYLATE 653 497 2 4
LISINOPRIL 543 361 3 3
METFORMIN HCL 475 331 4 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 473 360 5 37
METOPROLOL TARTRATE 317 218 6 7
OMEPRAZOLE 290 193 7 1
HYDROCHLOROTHIAZIDE 264 191 8 8
LEVOTHYROXINE SODIUM 241 191 9 5
TRAMADOL HCL 239 165 10 26
NIFEDIPINE ER 235 178 11 89
CLONIDINE HCL 219 156 12 52
GABAPENTIN 214 119 13 15
IBUPROFEN 193 127 14 14
CRESTOR 170 123 15 9
RANITIDINE HCL 164 135 16 17
POTASSIUM CHLORIDE 161 120 17 28
BUMETANIDE 154 116 18 123
LOSARTAN POTASSIUM 154 134 18 18
FUROSEMIDE 153 110 20 10
ATENOLOL 151 112 21 11
ATORVASTATIN CALCIUM 148 92 22 33
CARVEDILOL 146 72 23 20
LANTUS 122 89 24 56
INSULIN SYRINGE 120 72 25 79
WARFARIN SODIUM 112 82 26 38
GLIPIZIDE 108 72 27 42
ENALAPRIL MALEATE 106 74 28 35
VENTOLIN HFA 104 53 29 96
MELOXICAM 102 76 30 41
METFORMIN HCL ER 98 78 31 143
NAPROXEN 97 80 32 65
GLYBURIDE 92 74 R 33 64
ACETAMINOPHEN-CODEINE 86 48 S3 34 192
PLAVIX 83 55 35 24
ALENDRONATE SODIUM 82 79 36 16
CLOPIDOGREL 81 63 37 19
ALLOPURINOL 79 71 38 47
DIOVAN 79 67 38 30
ZOLPIDEM TARTRATE 78 16 40 13
DIGOXIN 78 48 40 69
CHLORTHALIDONE 73 61 42 184
AZITHROMYCIN 72 44 43 44
ADVAIR DISKUS 72 44 43 27
TRIAMTERENE-HCTZ 68 57 45 120
DIOVAN HCT 68 49 45 51
CYCLOBENZAPRINE HCL 65 27 R 47 99
DOXAZOSIN MESYLATE 65 38 47 73
JANUVIA 63 29 49 80
AMOXICILLIN 61 35 50 174
AMLODIPINE BESYLATE-BENAZEPRIL 60 47 51 72
GLIPIZIDE ER 58 54 52 107
PROAIR HFA 58 17 52 66
NEXIUM 57 29 54 12
CYPROHEPTADINE HCL 56 45 R 55 258
LOVASTATIN 54 54 56 25
DONEPEZIL HCL 54 54 56 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.